MoneyWorks4Me

Emmessar Biotech&Nut - Quaterly Results

20 Oct 2021 Evaluate
The Sales for the quarter ended September 2021 of Rs. 0.36 million declined by -96.64% from Rs. 10.71 millions.Profit after Tax for the quarter ended September 2021 saw a decline of -59.47% from Rs. 4.54 millions to Rs. 1.84  millions.A decline of 2.02 millions was observed in the OP in the quarter ended September 2021 from 4.68 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.36 10.71 -96.64 0.59 13.63 -95.67 69.91 33.96 105.86
Other Income 4.27 3.69 15.72 8.05 5.63 42.98 14.66 14.65 0.07
PBIDT 2.02 4.68 -56.84 3.03 5.07 -40.24 23.12 10.59 118.32
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 2.02 4.68 -56.84 3.03 5.07 -40.24 23.12 7.95 190.82
Depreciation 0.18 0.14 28.57 0.32 0.28 14.29 0.58 0.58 0.00
PBT 1.84 4.54 -59.47 2.71 4.79 -43.42 22.54 7.37 205.83
TAX 0.00 0.00 0.00 0.00 -0.06 0.00 8.05 -0.17 -4835.29
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 4.48 -0.20 -2340.00
PAT 1.84 4.54 -59.47 2.71 4.85 -44.12 14.49 7.54 92.18
Equity 49.96 49.96 0.00 49.96 49.96 0.00 49.96 49.96 0.00
PBIDTM(%) 561.11 43.70 1184.08 513.56 37.20 1280.63 33.07 31.18 6.05
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..